PCSK9 and hepatocellular carcinoma: Previous studies in this regard have demonstrated that the inhibition of cholesterol esterification not only effectively inhibits HCC development28 but also enhances the T cell-mediated anti-tumor immune response22, 29, and relevant studies have also documented that the inhibition of PCSK9 can promote anti-tumor effects by reprogramming cholesterol metabolism in a range of cancer types12.